| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/19/1997 | EP0763022A1 Phenoxyalkyl substituted piperidines, pyrrolidines, morpholines and thiomorpholines as calcium channel antagonists |
| 03/19/1997 | EP0763021A1 Phenoxyalkyl substituted piperidines, pyrrolidines, morpholines and tiomorpholines as calcium channel antagonists |
| 03/19/1997 | EP0763013A1 Hydroxylamine derivatives and their use as metalloproteinase inhibiting agents |
| 03/19/1997 | EP0667770B1 Inhibition of tnf production |
| 03/19/1997 | EP0634998B1 Hydroxamic acid based collagenase and cytokine inhibitors |
| 03/19/1997 | EP0566641B1 Use of human igf-i |
| 03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
| 03/19/1997 | CN1145618A New piperidine derivatives |
| 03/19/1997 | CN1145360A Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same |
| 03/19/1997 | CN1145244A Chinese medicine for lowering PTA rear narrow replapse rate |
| 03/19/1997 | CN1145230A High content ginko leaves flavone lactone extract and its prepn. method |
| 03/19/1997 | CN1145223A Endothelin receptor antagonists |
| 03/19/1997 | CA2185737A1 Amid and urea derivatives |
| 03/19/1997 | CA2182541A1 Novel, ubiquitous potassium-channel proteins and genes for the same |
| 03/18/1997 | US5612373 Certain diacyl hydrazine derivatives |
| 03/18/1997 | US5612369 Treatment of arterial and venous thrombotic occlusive disorders, inflammation, cancer, and neurodegenerative diseases |
| 03/18/1997 | US5612367 Method of enhancing bioavailability of pharmaceutical agents |
| 03/18/1997 | US5612365 Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease |
| 03/18/1997 | US5612360 Aromatic n-heterocyclic compounds as hypotensive agents with acid groups, sulfonylcarboxamides or tetrazole groups |
| 03/18/1997 | US5612359 Substituted biphenyl isoxazole sulfonamides |
| 03/18/1997 | US5612352 Inhibitors of squalene synthase and anticholesterol agents with biphenylquinuclidine derivatives |
| 03/18/1997 | US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms |
| 03/18/1997 | US5612335 Anticoagulants; combating/preventing diseases where cell aggregates occur or cell-matrix interactions play a part |
| 03/18/1997 | US5612334 Tricyclic benzazepine vasopressin antagonists |
| 03/18/1997 | US5612325 Antiinflammatory and immunomodulating effects |
| 03/18/1997 | US5612318 Control of gene expression by ionizing radiation |
| 03/18/1997 | US5612314 Nitrosylated neuropeptides |
| 03/18/1997 | US5612194 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/18/1997 | CA2008341C Benzocycloalcenyl dihydroxy alcanoic acid derivatives, process for their preparation and drugs containing the same |
| 03/15/1997 | CA2185517A1 Use of cytohesin-ph peptides for influencing the ability of integrins to adhere |
| 03/13/1997 | WO1997009427A1 Vegf-related protein |
| 03/13/1997 | WO1997009348A2 Orphan receptor |
| 03/13/1997 | WO1997009318A1 Pyrimidine derivatives |
| 03/13/1997 | WO1997009311A1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 03/13/1997 | WO1997009306A1 Novel isothiourea derivatives |
| 03/13/1997 | WO1997009294A1 Carboxylic acid derivatives, their preparation and their use |
| 03/13/1997 | WO1997009056A1 Extract of iridaceae and compositions containing such extract |
| 03/13/1997 | WO1997009051A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof |
| 03/13/1997 | WO1997009049A2 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 03/13/1997 | WO1997009048A1 Use of a thienotriazolodiazepine to increase apolipoprotein a-i levels |
| 03/13/1997 | WO1997009046A1 Compounds and methods |
| 03/13/1997 | WO1997009032A1 Utilization of an extract of a non photosynthetic filamentary bacterium and composition containing such extract |
| 03/13/1997 | DE19533025A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use |
| 03/13/1997 | CA2231400A1 Vegf-related protein |
| 03/13/1997 | CA2230687A1 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 03/13/1997 | CA2230477A1 Use of a thienotriazolodiazepine to increase apolipoprotein a-i levels |
| 03/13/1997 | CA2230385A1 Analogs for specific oliogosaccharide-neuregulin interactions and uses thereof |
| 03/13/1997 | CA2228002A1 Novel carboxylic acid derivatives, their preparation and use |
| 03/12/1997 | EP0761661A1 Glycomimetics as selectin antagonists, and anti-inflammatory agents prepared thereof |
| 03/12/1997 | EP0761659A1 Naphthyl and dihydronaphthyl compounds as medicaments |
| 03/12/1997 | EP0761204A1 Use of extracts of filamentous, non photosynthetic bacteria and the composition containing them |
| 03/12/1997 | EP0760819A1 Tricyclic dicarbonyl derivatives |
| 03/12/1997 | EP0760818A1 Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 03/12/1997 | EP0760811A1 Imidazole derivatives as histamine receptor h 3? (ant)agonists |
| 03/12/1997 | EP0760685A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 03/12/1997 | EP0760682A1 Gene transfer-mediated angiogenesis therapy |
| 03/12/1997 | EP0760676A1 Materials and methods for treatment of plaquing diseases |
| 03/12/1997 | EP0760666A1 Use of oligonucleotide phosphorothioate for depleting complement and for reducing blood pressure |
| 03/12/1997 | EP0760664A1 Use of pteridine derivatives as no-synthase inhibitors |
| 03/12/1997 | EP0693059B1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same |
| 03/12/1997 | EP0673378B1 New triazolopyrimidones, their preparation and their use |
| 03/12/1997 | EP0648207B1 Vitamin d analogues |
| 03/12/1997 | EP0627919B1 Application of 2-amino 6-trifluoromethoxy benzothiazole (riluzole) for obtaining a drug useful in the treatment of motor neuron diseases |
| 03/12/1997 | EP0618798B1 Pyridylguanidine compounds for treatment of erectile dysfunction |
| 03/12/1997 | EP0561876B1 Use of angiotensin ii receptor antagonists in the treatment of atheroma |
| 03/12/1997 | CN1145075A Antagonist's of endothelin receptors |
| 03/12/1997 | CN1145027A Use of insulin sensitisers for treating renal diseases |
| 03/12/1997 | CN1144800A 3-substituted oxindole derivatives as potassium channel modulators |
| 03/12/1997 | CN1144656A Pharmaceutical compositions containing irbesartan |
| 03/11/1997 | US5610308 Process for preparing intermediates for thrombin inhibitors |
| 03/11/1997 | US5610295 4-amino-2-(hetero)aryl-butanamides useful as 5-HT1A -antagonists |
| 03/11/1997 | US5610182 Administering an isocarbacyclin of specific structure in the form of a fat emulsion |
| 03/11/1997 | US5610176 Tachykinin (NK1) receptor antagonists |
| 03/11/1997 | US5610172 Sulfonamidocarbonylpyridine-2-carboxamides and pyridine-n-oxides which are useful as pharmaceuticals |
| 03/11/1997 | US5610166 Methods for inhibiting angiogenesis |
| 03/11/1997 | US5610156 Tricyclic benzazepine vasopressin antagonists |
| 03/11/1997 | US5610154 Bicyclic carboxamides |
| 03/11/1997 | US5610153 Benzazepinone derivatives |
| 03/11/1997 | US5610151 Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
| 03/11/1997 | US5610146 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use |
| 03/11/1997 | US5610145 Carbamate stereoisomers |
| 03/11/1997 | US5610134 Treatment of congestive heart failure |
| 03/11/1997 | EP0699442A4 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties |
| 03/11/1997 | CA2015505C Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels |
| 03/07/1997 | CA2184881A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity prepared therefrom |
| 03/06/1997 | WO1997008174A1 Interleukin converting enzyme and apoptosis |
| 03/06/1997 | WO1997008166A1 Piperazino derivatives as neurokinin antagonists |
| 03/06/1997 | WO1997008133A1 Amide compounds and use of the same |
| 03/06/1997 | WO1997007801A1 New applications of 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropyridine-3-carboxylate of 2-[n-(1,2-benzisothiazolyl-3(2h)one-1,1-dioxide]ethyl |
| 03/06/1997 | WO1997005285A3 Methods and compositions for identifying morphogen analogs |
| 03/06/1997 | CA2502764A1 Amide compounds |
| 03/06/1997 | CA2203624A1 New applications of 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropyridine-3-carboxylate of 2-¬n-(1,2-benzisothiazolyl-3(2h)one-1,1-dioxide¦ethyl |
| 03/05/1997 | EP0760365A2 Alkenyl-benzoylguanidines |
| 03/05/1997 | EP0760241A1 Use of sulfasalazine and its active metabolite for the manufacture of a medicament for the treatment of venous insufficiency and venous ulcers |
| 03/05/1997 | EP0759983A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759978A1 Neurotransmitter transporter |
| 03/05/1997 | EP0759934A1 Neurotensin antagonist peptides |
| 03/05/1997 | EP0759918A1 Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists |
| 03/05/1997 | EP0759899A1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |